Position in JNJ
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$16,964,434
+$563,977 QoQ
Shares Held
66,797
-0.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
2.29%
of 13F equity value
Holder Rank
#817
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WILKINS INVESTMENT COUNSEL INC holds $77,139,543 across 7 Drug Manufacturers - General names. JNJ ranks #3 (22.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
244,471 | $31,414,523 | |
| 2 | NVS |
Novartis AG
|
111,067 | $17,406,420 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
66,797 | $16,964,434 | |
| 4 | PFE |
Pfizer Inc
|
176,761 | $4,256,404 | |
| 5 | ABBV |
AbbVie Inc.
|
14,832 | $3,732,324 | |
| 6 | LLY |
ELI LILLY & Co
|
2,484 | $2,979,384 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
6,700 | $386,054 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,964,434 | 66,797 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $16,400,457 | 67,094 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $20,477,702 | 98,950 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $20,940,036 | 112,933 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $18,557,597 | 121,490 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $21,072,127 | 127,063 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $18,204,765 | 125,880 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $20,845,615 | 128,629 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $18,685,386 | 127,842 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $19,152,696 | 121,074 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $12,832,460 | 81,871 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $11,879,987 | 76,276 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $12,492,787 | 75,476 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $11,667,470 | 75,274 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $13,277,367 | 75,162 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $12,286,632 | 75,212 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $13,350,882 | 75,212 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $13,431,198 | 75,784 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $13,074,709 | 76,429 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $12,317,443 | 76,269 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $12,584,653 | 76,391 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $12,151,381 | 73,936 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $11,783,984 | 74,876 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $11,409,269 | 76,634 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $10,731,334 | 76,309 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $10,052,294 | 76,659 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||